SCD expression in glioblastoma tumors may be locally increased, as it is increased by activation of EGFR [71] and platelet-derived growth factor receptor (PDGFR) [72], which activate sterol regulatory element-binding protein 1 (SREBP1) through these receptors. This evidence concerns the gene EGFR and glioblastoma.